IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide
- PMID: 10553050
IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide
Abstract
NO and IFN-gamma have normally been considered cytotoxic and proinflammatory molecules, respectively, in the setting of the central nervous system inflammatory disease autoimmune encephalomyelitis (EAE). Using mice lacking the ligand binding chain of the IFN-gamma receptor (IFNgammaR-/-), we have previously shown that IFN-gamma is not essential for myelin oligodendrocyte glycoprotein peptide (MOG35-55) induced EAE expression but is in fact essential for its down-regulation. Here we examined the downstream molecular and cellular mechanism(s) of IFN-gamma regulation and demonstrate that neither IL-4 nor IL-10 appear to play a role in down-regulation nor do various lymphoid cell populations. Cells of the macrophage lineage are key to down-regulation as evidenced by the fact that peritoneal exudate cells from IFNgammaR+/+ mice inhibit Ag-driven proliferation of IFNgammaR-/- lymphocytes, whereas IFNgammaR-/- peritoneal exudate cells do not. High levels of reactive nitrogen intermediates are detected in the former cultures but not the latter, and the inhibition of proliferation is reversible with an inhibitor of inducible NO synthase, indicating a key role for NO in down-regulation. Studies with bone marrow chimeras indicate that down-regulation occurs not only systemically but also within the target tissue. These data suggest that IFN-gamma down-regulates EAE by inducing inducible NO synthase and subsequently NO production, both by macrophages in the periphery and, by inference, microglia and astrocytes in the target tissue.
Similar articles
-
IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).Scand J Immunol. 2002 Feb;55(2):171-7. Scand J Immunol. 2002. PMID: 11896933
-
IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.Mol Immunol. 2008 Feb;45(4):1191-6. doi: 10.1016/j.molimm.2007.07.003. Epub 2007 Aug 13. Mol Immunol. 2008. PMID: 17697713
-
[TH1 response in the experimental infection with Trypanosoma cruzi].Medicina (B Aires). 1999;59 Suppl 2:84-90. Medicina (B Aires). 1999. PMID: 10668248 Spanish.
-
The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis.J Neuroimmunol. 2007 Nov;191(1-2):16-25. doi: 10.1016/j.jneuroim.2007.09.007. Epub 2007 Sep 29. J Neuroimmunol. 2007. PMID: 17904645 Review.
-
Nitric oxide in interstitial nephritis and other autoimmune diseases.Semin Nephrol. 1999 May;19(3):288-95. Semin Nephrol. 1999. PMID: 10226335 Review.
Cited by
-
Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis.J Exp Med. 2004 Jul 5;200(1):79-87. doi: 10.1084/jem.20031819. J Exp Med. 2004. PMID: 15238607 Free PMC article.
-
Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains.Brain Pathol. 2000 Jul;10(3):402-18. doi: 10.1111/j.1750-3639.2000.tb00272.x. Brain Pathol. 2000. PMID: 10885659 Free PMC article.
-
Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via an iNKT cell-dependent mechanism.Am J Pathol. 2009 Sep;175(3):1116-23. doi: 10.2353/ajpath.2009.090265. Epub 2009 Aug 21. Am J Pathol. 2009. PMID: 19700760 Free PMC article.
-
Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.Adv Immunol. 2009;103:77-115. doi: 10.1016/S0065-2776(09)03004-1. Adv Immunol. 2009. PMID: 19755184 Free PMC article. Review.
-
Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis.Therapy. 2008 Sep 1;5(5):631-640. doi: 10.2217/14750708.5.5.631. Therapy. 2008. PMID: 20357912 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases